drugset
drugset / Trial / NCT00096187

Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy

NCT00096187 ↗

Phase 2 Terminated 55 enrolled Gynecologic Oncology Group National Cancer Institute (NCI) · collab
Open-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as pemetrexed disodium, work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying how well pemetrexed disodium works in treating patients with recurrent or persistent low-risk gestational trophoblastic tumor after a molar pregnancy.

Timeline

Start
2005-07
Primary completion
2007-07-23
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Pemetrexed Small molecule — —

Indications

gestational trophoblastic neoplasm